Active, not recruitingPhase 3NCT02288962

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

Studying Functioning pituitary adenoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
St. Olavs Hospital
Principal Investigator
Sven M Carlsen, prof md
Norwegian University of Science and Technology
Intervention
cabergoline(drug)
Enrollment
60 enrolled
Eligibility
18-75 years · All sexes
Timeline
20142028

Study locations (3)

Collaborators

Norwegian University of Science and Technology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02288962 on ClinicalTrials.gov

Other trials for Functioning pituitary adenoma

Additional recruiting or active studies for the same condition.

See all trials for Functioning pituitary adenoma

← Back to all trials